Company: MYSZ
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001641172-25-000990
Chunk: 1467

Company: My Size, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 8
Chunk 1467
---
 control over financial reporting may not prevent or detect misstatements. Also, projections of
any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions,
or that the degree of compliance with the policies or procedures may deteriorate.

Our
management, including our Chief Executive Officer and Chief Financial Officer, assessed the effectiveness of our internal control over
financial reporting at December 31, 2024. In making this assessment, management used the criteria set forth by the Committee of Sponsoring
Organizations of the Treadway Commission (COSO) in Internal Control—Integrated Framework (2013). Based on that assessment under
those criteria, management has determined that, as of December 31, 2024, our internal control over financial reporting was effective.

This
Annual Report on Form 10-K does not include an attestation report of our registered public accounting firm regarding internal control
over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting
firm pursuant to the exemption provided to issuers that are not “large accelerated filers” nor “accelerated filers”
under the Dodd-Frank Wall Street Reform and Consumer Protection Act.

Changes
in Internal Control Over Financial Reporting

During
the most recent fiscal quarter, no change has occurred in our internal control over financial reporting that has materially affected,
or is reasonably likely to materially affect, our internal control over financial reporting.

ITEM
9B. OTHER INFORMATION

During
the quarter ended December 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1
trading arrangement” or a “non-Rule 10b5-1 trading arrangement” (in each case, as defined in Item 408 of Regulation
S-K) except as set forth below:

●On
                                            December 26, 2024, Ronen Luzon, our Chief Executive Officer, terminated a Rule 10b5-1 trading
                                            arrangement for the potential sale of up to 13,086 shares of common stock, none of which
                                            were sold. The arrangement was initially adopted on August 31, 2023.

●On
                                            December 26, 2024, Or Kles, our Chief Financial Officer, terminated a Rule 10b5-1 trading
                                            arrangement for the potential sale of up to 3,720 shares of common stock, none of which